RupeshRajeshKotechaMD

Chief of Radiosurgery | Director of CNS Metastasis | Miami Cancer Institute | Baptist Health South Florida

Overview of Dr. Kotecha

Rupesh Kotecha, M.D., is a radiation oncologist at Miami Cancer Institute. Dr. Kotecha has specialized training and experience in utilizing the latest in radiation therapy treatment techniques to treat cancer and noncancerous conditions. His research background and clinical interests have primarily focused on the treatment of patients with stereotactic radiosurgery and stereotactic body radiation therapy. He has a specific interest and expertise in the use of stereotactic radiosurgery in the management of brain metastases to help improve both patient outcomes and quality of life.

Office
8900 N Kendall Dr
# Miami
Miami, FL 33176
Book by Phone+1(786) 706-1593

Fax+1 305-279-8887

Education & Training

Cleveland Clinic FoundationResidency, Radiation Oncology, 2012 - 2016
Michigan State University College of Human MedicineClass of 2012

Certifications & Licensure

FL State Medical License 2017 - 2025
OH State Medical License 2012 - 2017
American Board of Radiology Radiation Oncology

Clinical Trials

Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery Start of enrollment: 2022 Apr 04
Recruiting
Phase 1
Roles: Principal Investigator, Contact
Dose-Escalated Spine SbRT for Localized Metastasis to the Spinal Column Start of enrollment: 2021 Mar 14
Recruiting
Not Applicable
Roles: Contact, Principal Investigator
Study of LUNG Stereotactic Adaptive Ablative Radiotherapy Start of enrollment: 2022 May 02
Withdrawn
Not Applicable
Roles: Contact, Principal Investigator
Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation Start of enrollment: 2020 May 22
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
Cabozantinib for Patients With Recurrent or Progressive Meningioma Start of enrollment: 2022 May 27
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases Start of enrollment: 2023 Nov 17
Recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery Start of enrollment: 2024 Apr 11
Recruiting
Phase 1
Roles: Contact, Principal Investigator
Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease Start of enrollment: 2022 Aug 29
Recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator
Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis Start of enrollment: 2023 Jan 10
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic Start of enrollment: 2021 Nov 30
Recruiting
Roles: Principal Investigator, Contact
PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial Start of enrollment: 2024 Jun 01
Not yet recruiting
Not Applicable
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

268 citations
Current approaches to the management of brain metastases.
John H. Suh, Rupesh Kotecha, Samuel T. Chao, Manmeet Ahluwalia, Arjun Sahgal
Nature Reviews. Clinical Oncology. 2020-02-20
115 citations
Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline.
Vinai Gondi, Glenn Bauman, Lisa Bradfield, Stuart H Burri, Alvin R Cabrera
Practical Radiation Oncology. 2022-05-06
39 citations
Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases
Shireen Parsai, Jacob A. Miller, Aditya Juloori, Samuel T. Chao, Rupesh Kotecha
Journal of Neurosurgery. 2020-02-01

Journal Articles

Focus Issue: Imaging in Cardio-Oncology State-of-the-Art Paper Radiation-Associated Cardiac Disease: A Practical Approach to Diagnosis and Management
Douglas R Johnston, Brian P Griffin, Rupesh Kotecha, Christine L Jellis, Milind Y Desai, ScienceDirect

Press Mentions

How Miami Cancer Institute's World-Class Radiation Therapy Team Is Changing LivesOctober 3rd, 2024
Cantex and Miami Cancer Institute Announce FDA Clearance for a Clinical Trial Investigating Azeliragon Combined with Stereotactic Radiosurgery for the Treatment of Brain MetastasesMarch 6th, 2023
Glioblastoma Patient Enrolls in Novel Clinical Trial Using Proton Therapy to Augment SurvivalJune 2nd, 2022
Join now to see all

External Links

For more information on Miami Cancer Institute, visithttps://cancer.baptisthealth.net/miami-cancer-institute
To refer a patient, visithttps://cancer.baptisthealth.net/miami-cancer-institute/healthcare-professionals/referring-patients